Martin Boeree
Martin Boeree
Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
Antituberculosis drug‐induced hepatotoxicity: concise up‐to‐date review
A Tostmann, MJ Boeree, RE Aarnoutse, WCM De Lange, ...
Journal of gastroenterology and hepatology 23 (2), 192-202, 2008
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study
W Hoefsloot, J Van Ingen, C Andrejak, K Ängeby, R Bauriaud, P Bemer, ...
European Respiratory Journal 42 (6), 1604-1613, 2013
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar, LF Anderson, ...
The Lancet 392 (10150), 821-834, 2018
Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands
A Tostmann, SV Kik, NA Kalisvaart, MM Sebek, S Verver, MJ Boeree, ...
Clinical Infectious Diseases 47 (9), 1135-1142, 2008
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
MJ Boeree, N Heinrich, R Aarnoutse, AH Diacon, R Dawson, S Rehal, ...
The Lancet infectious diseases 17 (1), 39-49, 2017
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis
MJ Boeree, AH Diacon, R Dawson, K Narunsky, J Du Bois, A Venter, ...
American journal of respiratory and critical care medicine 191 (9), 1058-1065, 2015
Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria
J van Ingen, MJ Boeree, D van Soolingen, JW Mouton
Drug Resistance Updates 15 (3), 149-161, 2012
New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development
J van den Boogaard, GS Kibiki, ER Kisanga, MJ Boeree, RE Aarnoutse
Antimicrobial agents and chemotherapy 53 (3), 849-862, 2009
Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence
MA Gordon, HT Banda, M Gondwe, SB Gordon, MJ Boeree, AL Walsh, ...
Aids 16 (12), 1633-1641, 2002
Characterization of Mycobacterium orygis as M. tuberculosis complex subspecies
J van Ingen, Z Rahim, A Mulder, MJ Boeree, R Simeone, R Brosch, ...
Emerging infectious diseases 18 (4), 653, 2012
Nontuberculous mycobacteria in respiratory tract infections, eastern Asia
S Simons, J Van Ingen, PR Hsueh, N Van Hung, PNR Dekhuijzen, ...
Emerging infectious diseases 17 (3), 343, 2011
Why do we use 600 mg of rifampicin in tuberculosis treatment?
J Van Ingen, RE Aarnoutse, PR Donald, AH Diacon, R Dawson, ...
Clinical Infectious Diseases 52 (9), e194-e199, 2011
Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands
J van Ingen, SA Bendien, WCM de Lange, W Hoefsloot, PNR Dekhuijzen, ...
Thorax 64 (6), 502-506, 2009
Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study
JM Bryant, SR Harris, J Parkhill, R Dawson, AH Diacon, P van Helden, ...
The Lancet Respiratory Medicine 1 (10), 786-792, 2013
Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers
CJL La Porte, EPH Colbers, R Bertz, DS Voncken, K Wikstrom, MJ Boeree, ...
Antimicrobial agents and chemotherapy 48 (5), 1553-1560, 2004
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
GB Migliori, S Tiberi, A Zumla, E Petersen, JM Chakaya, C Wejse, ...
International Journal of Infectious Diseases 92, S15-S25, 2020
Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment
SO Friedrich, A Rachow, E Saathoff, K Singh, CD Mangu, R Dawson, ...
The lancet Respiratory medicine 1 (6), 462-470, 2013
The Pharmacokinetics and Pharmacodynamics of Pulmonary Mycobacterium avium Complex Disease Treatment
J van Ingen, EF Egelund, A Levin, SE Totten, MJ Boeree, JW Mouton, ...
American journal of respiratory and critical care medicine 186 (6), 559-565, 2012
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
S Borisov, E Danila, A Maryandyshev, M Dalcolmo, S Miliauskas, L Kuksa, ...
European Respiratory Journal 54 (6), 2019
Care seeking behaviour and diagnostic processes in patients with smear-positive pulmonary tuberculosis in Malawi
FML Salaniponi, AD Harries, HT Banda, C Kang'ombe, N Mphasa, ...
The International Journal of Tuberculosis and Lung Disease 4 (4), 327-332, 2000
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20